
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group is supported by massive scale in medical benefits and a diversified Optum platform that spans pharmacy benefits, outpatient care, and analytics, giving it broad exposure across the U.S. healthcare continuum and improving earnings visibility. Its 3Q26 adjusted EPS of $4.69 beat consensus, MCR was better than expected, and management lifted 2026 adjusted EPS guidance to at least $20.50, while Medicare Advantage margins are trending near the top of the 2% to 4% range and Medicaid appears to be at or near a trough. The bullish case also rests on durable OptumHealth execution, external growth at Optum Rx, and strong cash flow with a solid balance sheet, all of which support margin expansion, disciplined pricing, and continued double-digit long-term earnings growth.
Bears say
UnitedHealth Group is facing a deteriorating fundamental backdrop as accelerating Medicare Advantage utilization, commercial medical-cost pressure, and weak visibility into near-term MLR trends threaten earnings quality and margin stability. The downside case assumes FY28 EPS about 10% below base case and a lower 15.0x multiple, reflecting risks from network contracting, reimbursement pressure in the government business, and regulatory scrutiny that could hit MA, PBM, and Medicaid profitability. Continued IDR, specialty-drug, and provider coding-intensity inflation, along with potential CMS reimbursement cuts and increased MA competition, further cloud the earnings path and justify a cautious stance.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About UnitedHealth Group (UNH) Forecast
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares